ACHE and Alzheimer disease: Several AD patients had initiated acetylcholine esterase inhibitor treatment at the time of sampling or just prior; therefore, given that timing, it is unlikely that acetylcholinesterase inhibitors affect the saliva metabolites or proteins as measured in this study.